Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-044509
Filing Date
2025-05-05
Accepted
2025-05-05 16:09:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm252585d3_defa14a.htm DEFA14A 9512
2 GRAPHIC tm252585d3_defa14aimg001.jpg GRAPHIC 353512
3 GRAPHIC tm252585d3_defa14aimg002.jpg GRAPHIC 123461
  Complete submission text file 0001104659-25-044509.txt   668051
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14778 | Film No.: 25913007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)